Titan Pharmaceuticals, Inc. (TTNP)
NASDAQ: TTNP · Real-Time Price · USD
3.380
+0.110 (3.36%)
Dec 20, 2024, 4:00 PM EST - Market closed
Titan Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 0 | 0.18 | 0.56 | 1.53 | 4.84 | 2.61 | Upgrade
|
| Revenue Growth (YoY) | -99.24% | -66.97% | -63.50% | -68.46% | 85.72% | -60.64% | Upgrade
|
| Cost of Revenue | 0.91 | 1.91 | 4.76 | 5.89 | 6.39 | 5.08 | Upgrade
|
| Gross Profit | -0.91 | -1.73 | -4.2 | -4.37 | -1.55 | -2.48 | Upgrade
|
| Selling, General & Admin | 6.22 | 5.55 | 6.03 | 4.99 | 5.8 | 5.4 | Upgrade
|
| Operating Expenses | 6.22 | 5.55 | 6.03 | 4.99 | 5.8 | 5.4 | Upgrade
|
| Operating Income | -7.13 | -7.28 | -10.24 | -9.35 | -7.35 | -7.88 | Upgrade
|
| Interest Expense | -0.02 | - | - | - | -0.77 | -0.97 | Upgrade
|
| Interest & Investment Income | - | 0.01 | 0.05 | 0 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.06 | -0.05 | -0.02 | -0.08 | 0.79 | 1.13 | Upgrade
|
| EBT Excluding Unusual Items | -7.22 | -7.32 | -10.21 | -9.44 | -7.33 | -7.72 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.76 | 1.76 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | 0.66 | -0.08 | 0.23 | Upgrade
|
| Pretax Income | -5.46 | -5.57 | -10.21 | -8.78 | -7.41 | -7.49 | Upgrade
|
| Earnings From Continuing Operations | -5.46 | -5.57 | -10.21 | -8.78 | -7.41 | -7.49 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | -10.84 | -8.97 | Upgrade
|
| Net Income | -5.46 | -5.57 | -10.21 | -8.78 | -18.24 | -16.46 | Upgrade
|
| Net Income to Common | -5.46 | -5.57 | -10.21 | -8.78 | -18.24 | -16.46 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 1 | 1 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 10.30% | 11.90% | 38.13% | 157.88% | 392.56% | 92.14% | Upgrade
|
| EPS (Basic) | -6.67 | -7.41 | -15.19 | -18.04 | -96.70 | -429.71 | Upgrade
|
| EPS (Diluted) | -6.67 | -7.41 | -15.19 | -18.04 | -96.70 | -429.71 | Upgrade
|
| Free Cash Flow | -6.76 | -7.09 | -8.18 | -7.92 | -17.74 | -15.7 | Upgrade
|
| Free Cash Flow Per Share | -8.26 | -9.43 | -12.18 | -16.28 | -94.05 | -409.95 | Upgrade
|
| Gross Margin | - | - | - | -286.04% | -32.04% | -95.01% | Upgrade
|
| Operating Margin | -237633.33% | -3954.89% | -1837.52% | -612.98% | -151.94% | -302.34% | Upgrade
|
| Profit Margin | -182033.33% | -3026.63% | -1832.32% | -575.10% | -377.06% | -631.79% | Upgrade
|
| Free Cash Flow Margin | -225466.67% | -3855.43% | -1469.12% | -519.13% | -366.74% | -602.73% | Upgrade
|
| EBITDA | -7.09 | -7.17 | -10.04 | -9.13 | -7.06 | -7.63 | Upgrade
|
| EBITDA Margin | - | - | - | - | -145.91% | -292.98% | Upgrade
|
| D&A For EBITDA | 0.04 | 0.11 | 0.2 | 0.22 | 0.29 | 0.24 | Upgrade
|
| EBIT | -7.13 | -7.28 | -10.24 | -9.35 | -7.35 | -7.88 | Upgrade
|
| EBIT Margin | - | - | - | - | -151.94% | - | Upgrade
|
| Revenue as Reported | 0 | 0.18 | 0.56 | 1.53 | 4.84 | 2.61 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.